Jeffrey Edward Nelson

Jeffrey Edward Nelson is a declared insider of Milestone Pharmaceuticals Inc., with filings sourced from SEC (Form 4). The record holds 4 filings, for trades running from 12 December 2025 to 26 January 2026.

Sales make up the whole of the open-market record (2 sales, €135k). The rest of the record consists of 1 share grant and 1 option exercise. Since January 2026: no purchases and 2 sales on the market.

Most recently, on 28 January 2026, the filings show an open-market sale worth €115k in Milestone Pharmaceuticals Inc. Typically, a trade is published a median of 23 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.